Research Progress on the Treatment of Vascular Vertigo with Active Ingredients of Pueraria Lobata

Abstract

Vascular vertigo is a common disease among middle-aged and elderly patients with vertigo, caused by cerebrovascular diseases, which seriously affects the quality of life of patients. Its pathogenesis is diverse, and there is still a lack of clear and effective therapeutic drugs in clinical practice. Pueraria lobata, as a commonly used traditional Chinese medicine for treating brain diseases, is widely used in clinical practice and has great development prospects. By summarizing the network pharmacology and clinical medication rules of vascular vertigo, it was found that Pueraria lobata is a high-frequency single traditional Chinese medicine for treating this disease. Modern pharmacological research has found that the main components of Pueraria lobata, such as isoflavones, triterpenes, coumarins, and alkaline compounds, can all play a preventive and therapeutic role in vascular dizziness. This article summarizes the published domestic and foreign papers and experiments, and takes the pathogenesis of vascular vertigo and the pharmacological characteristics of Pueraria lobata as a breakthrough point. Through sorting, it was found that Pueraria lobata exerts pharmacological effects in improving vascular endothelial function, regulating lipid metabolism, anticoagulation and antithrombotic effects, inhibiting oxidative stress, and regulating inflammatory reactions, and has significant effects on the clinical treatment of vascular vertigo.